JJ

Jacinth Jackie Fairley

Mirrabooka Investments Limited | Non-Executive Director
Dr Fairley has more than 30 years of operational experience in the pharmaceutical and biotechnology industries working in senior management roles with companies including CSL and Faulding (now Pfizer) and has most recently joined the board of Calvary Healthcare, which operates hospitals and aged care facilities. Dr Fairley is also a Director of the Baker Heart and Diabetes Institute and a member of the Victorian Trade and Investment Advisory Board and acted as an adviser to the Carnegie Innovation Fund for more than 10 years. Dr Fairley is a past Director of Starpharma and the Melbourne Business School and past member of the Australian Federal Government's Commonwealth Science Council, Pharmaceutical Industry Working Group. She has also participated in a number of federal and state government Ministerial advisory councils in pharmaceuticals, economic development and innovation. She is Member of the Investment Committee.

Company and Role

Company
Title
Tenure
Since
MIR
Mirrabooka Investments Limited
  • Non-Executive Director
8yrs, 5mthFeb 2018

Holdings

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
MIR
Mirrabooka Investments Limited
17/02/26053,588N/AN/A
30/06/234,055,434N/AN/AN/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
MIR
Mirrabooka Investments Limited
17/02/26
Issued
780$3.050$2,379Dividend Reinvestment Plan (DRP)
MIR
Mirrabooka Investments Limited
19/08/25
Issued
1,020$3.300$3,366Dividend Reinvestment Plan (DRP)
MIR
Mirrabooka Investments Limited
10/06/25
Issued
6,474$3.060$19,810Rights issue
MIR
Mirrabooka Investments Limited
18/02/25
Issued
593$3.390$2,010Dividend Reinvestment Plan (DRP)
MIR
Mirrabooka Investments Limited
16/08/24
Issued
1,181$3.319$3,920Dividend Reinvestment Plan (DRP)